Private Advisor Group LLC Invests $208,000 in HealthEquity, Inc. (NASDAQ:HQY)

Private Advisor Group LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,544 shares of the company’s stock, valued at approximately $208,000.

Several other hedge funds also recently made changes to their positions in the business. International Assets Investment Management LLC bought a new position in HealthEquity in the second quarter valued at approximately $35,000. Paladin Wealth LLC bought a new position in HealthEquity in the third quarter valued at approximately $39,000. GAMMA Investing LLC increased its stake in HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in HealthEquity in the second quarter valued at approximately $73,000. Finally, Headlands Technologies LLC bought a new position in HealthEquity in the first quarter valued at approximately $130,000. 99.55% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. JMP Securities reissued a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Finally, Bank of America decreased their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, HealthEquity currently has a consensus rating of “Buy” and a consensus target price of $103.83.

HealthEquity Trading Up 1.7 %

HQY opened at $98.82 on Friday. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a fifty day moving average price of $83.15 and a two-hundred day moving average price of $80.43. The company has a market cap of $8.63 billion, a P/E ratio of 82.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.52. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $99.57.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock valued at $884,517 over the last three months. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.